AirOmatix is a developer of a biotechnology platform that improves methods of oxygen concentration, storage, and delivery.
AirOmatix provides oxygen concentration, storage, and delivery for use in healthcare, athletics, and food storage. Their technology uses photochemical reactions to separate oxygen from the air, which offers an alternative method for industrial applications and medical devices, enabling users to have an improved oxygen supply at any time.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Apr 11, 2022 | Grant | $256K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |